Tex. Occ. Code Section 562.0541
Emergency Refills of Insulin and Insulin-related Equipment or Supplies


(a)

In this section:

(1)

“Insulin” includes an insulin analog and an insulin-like medication, regardless of the activation period or whether the solution is mixed before the prescription is dispensed.

(2)

“Insulin-related equipment or supplies” includes needles, syringes, cartridge systems, prefilled pen systems, glucose meters, continuous glucose monitor supplies, and test strips, but excludes insulin pumps.

(b)

A pharmacist may provide an emergency refill of insulin or insulin-related equipment or supplies if the pharmacist complies with this section and rules adopted under this section.

(c)

Notwithstanding Section 562.054 (Emergency Refills)(a) and subject to Subsection (b) of this section, a pharmacist may exercise the pharmacist’s professional judgment in refilling a prescription for insulin or insulin-related equipment or supplies without the authorization of the prescribing practitioner if the pharmacist:

(1)

is unable to contact the practitioner after reasonable effort;

(2)

is provided with documentation showing that the patient was previously prescribed insulin or insulin-related equipment or supplies by a practitioner;

(3)

assesses the patient to determine whether the emergency refill is appropriate;

(4)

creates a record that documents the patient’s visit that includes a notation describing the documentation provided under Subdivision (2); and

(5)

makes a reasonable attempt to inform the practitioner of the emergency refill at the earliest reasonable time.

(d)

The quantity of an emergency refill of insulin may not exceed a 30-day supply. The quantity of an emergency refill of insulin-related equipment or supplies may not exceed the lesser of a 30-day supply or the smallest available package.

(e)

The prescribing practitioner is not liable for an act or omission by a pharmacist in dispensing an emergency refill of insulin or insulin-related equipment or supplies under this section.
Added by Acts 2021, 87th Leg., R.S., Ch. 679 (H.B. 1935), Sec. 1, eff. September 1, 2021.
Sec. 562.0545. 90-DAY SUPPLY AND ACCELERATED REFILLS. A pharmacist may dispense up to a 90-day supply of a dangerous drug pursuant to a valid prescription that specifies the dispensing of a lesser amount followed by periodic refills of that amount if:

(1)

the total quantity of dosage units dispensed does not exceed the total quantity of dosage units authorized by the prescriber on the original prescription, including refills;

(2)

the patient consents to the dispensing of up to a 90-day supply and the physician has been notified electronically or by telephone;

(3)

the physician has not specified on the prescription that dispensing the prescription in an initial amount followed by periodic refills is medically necessary;

(4)

the dangerous drug is not a psychotropic drug; and

(5)

the patient is at least 18 years of age.
Added by Acts 2011, 82nd Leg., R.S., Ch. 303 (H.B. 2069), Sec. 2, eff. September 1, 2011.

Source: Section 562.0541 — Emergency Refills of Insulin and Insulin-related Equipment or Supplies, https://statutes.­capitol.­texas.­gov/Docs/OC/htm/OC.­562.­htm#562.­0541 (accessed Jun. 5, 2024).

562.001
Definitions
562.002
Legislative Intent
562.003
Disclosure of Price
562.004
Prescription Transmitted Orally by Practitioner
562.005
Record of Dispensed Drug or Biological Product
562.006
Label
562.007
Refills
562.008
Generic Equivalent or Interchangeable Biological Product Authorized
562.009
Requirements Concerning Selection of Generically Equivalent Drug or Interchangeable Biological Product
562.010
Responsibility Concerning Generically Equivalent Drug or Interchangeable Biological Product
562.011
Restriction on Selection of and Charging for Generically Equivalent Drug or Interchangeable Biological Product
562.012
Substitution of Dosage Form Permitted
562.013
Applicability of Subchapter
562.014
Narrow Therapeutic Index Drugs
562.015
Dispensing Directive
562.016
List of Approved Interchangeable Biological Products
562.0051
Communication Regarding Certain Dispensed Biological Products
562.052
Release of Confidential Records
562.053
Reports to Board
562.054
Emergency Refills
562.055
Report to Texas Department of Health
562.056
Practitioner-patient Relationship Required
562.057
Administration of Epinephrine
562.0061
Other Prescription Information
562.0062
Required Statement Regarding Medication Disposal
562.101
Supervision of Pharmacy
562.102
Confidential Record
562.103
Display of Licenses by Pharmacy
562.104
Toll-free Telephone Number Required
562.105
Maintenance of Records
562.106
Notification
562.107
Written Consumer Information Required
562.108
Emergency Medication Kits
562.109
Automated Pharmacy Systems
562.110
Telepharmacy Systems
562.112
Practitioner-patient Relationship Required
562.0141
Transplant Immunosuppressant Drug Product Selection Prohibited
562.0142
Adoption of Rules
562.151
Definitions
562.152
Compounding for Office Use
562.153
Requirements for Office Use Compounding
562.154
Distribution of Compounded and Prepackaged Products to Certain Pharmacies
562.155
Compounding Service and Compounded Drug Products
562.156
Compounded Sterile Preparation
562.0541
Emergency Refills of Insulin and Insulin-related Equipment or Supplies
562.1011
Operation of Class C Pharmacy in Certain Rural Hospitals
562.1045
Linking Internet Sites
562.1085
Unused Drugs Returned by Certain Pharmacists
562.1086
Limitation on Liability

Accessed:
Jun. 5, 2024

§ 562.0541’s source at texas​.gov